The rising prevalence in GLP-1 agonists for diabetes has generated a discussion about formats: transdermal systems versus capsules. Traditionally , GLP-1 therapies were exclusively available in oral form, but the development of transdermal delivery provides a alternative option . Patches might benefit individuals with difficulty taking tablets ,… Read More